Key facts
- This page summarizes Eric Cribbs's Form 3 filing for EAGLE MATERIALS INC (EXP).
- 0 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 15 Aug 2022, 17:21.
Eric Cribbs - 05 Aug 2022 Form 3 Insider Report for EAGLE MATERIALS INC (EXP)
- Reporting relationship
- Executive Vice President
- Issuer ticker
- EXP
- Reported as of
- 05 Aug 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 15 Aug 2022, 17:21:21 UTC
- Next SEC filing
- 03 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Scott M. Wilson as Attorney-in-Fact for Eric Cribbs
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Eric Cribbs filed Form 3 for EAGLE MATERIALS INC (EXP) on 15 Aug 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 16,039
- Date
- 05 Aug 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EXP
holding
Derivative
Non-Qualified Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 05 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 791
- Exercise price
- $106.24
- Footnotes
- F2
EXP
holding
Derivative
Non-Qualified Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 05 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 735
- Exercise price
- $106.24
- Footnotes
- F3
EXP
holding
Derivative
Non-Qualified Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 05 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,824
- Exercise price
- $91.58
- Footnotes
- F4
EXP
holding
Derivative
Non-Qualified Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 05 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,568
- Exercise price
- $91.58
- Footnotes
- F5
EXP
holding
Derivative
Non-Qualified Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 05 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,292
- Exercise price
- $60.21
- Footnotes
- F6
EXP
holding
Derivative
Non-Qualified Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 05 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,911
- Exercise price
- $60.21
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
This number includes the following restricted shares: (a) 701 shares remaining from a grant awarded to the reporting person on 5/16/2019, the restrictions on which will lapse on 3/31/2023; (b) 3,083 shares remaining from a grant awarded to the reporting person on 5/19/2020, the restrictions on which will lapse ratably on March 31 of 2023 and 2024; (c) 2,666 shares remaining from a grant awarded to the reporting person on 5/19/2021, the restrictions on which will lapse ratably on March 31 of 2023, 2024 and 2025; and (d) 1,783 shares awarded to the reporting person on 5/19/2022, the restrictions on which will lapse ratably on March 31 of 2023, 2024, 2025 and 2026.
Footnote F2
On May 17, 2018, the reporting person was granted an option to purchase up to 3,528 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2019. On May 13, 2019, the performance conditions were determined to have been satisfied such that stock options vested as to 3,165 shares, 791 of which remain exercisable.
Footnote F3
On May 17, 2018 the reporting person was granted an option to purchase up to 2,940 shares of Common Stock, and currently 735 of these options remain exercisable.
Footnote F4
On May 16, 2019, the reporting person was granted an option to purchase up to 5,481 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2020. On May 4, 2020, the performance conditions were determined to have been satisfied such that stock options vested as to 4,824 shares. Currently 3,618 options are exercisable and the remaining options vest on March 31, 2023.
Footnote F5
On May 16, 2019 the reporting person was granted an option to purchase up to 4,568 shares of Common Stock. Currently 3,426 options are exercisable and the remaining options will vest on March 31, 2023.
Footnote F6
On May 19, 2020, the reporting person was granted an option to purchase up to 3,057 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2021. On May 6, 2021, the performance conditions were determined to have been satisfied such that stock options vested as to 3,057 shares. Currently 764 options are exercisable and the remaining options vest on March 31 of 2023 and 2024.
Footnote F7
On May 19, 2020 the reporting person was granted an option to purchase up to 2,548 shares of Common Stock. Currently 637 options are exercisable and the remaining options will vest ratably on March 31 of 2023 and 2024.